Core Viewpoint - Amplifon is conducting an Analyst and Investor Conference Call regarding the acquisition of GN Hearing, indicating a strategic move to enhance its market position in the hearing aid industry [1][2]. Group 1: Acquisition Details - The conference call is focused on the transaction involving GN Hearing, which is expected to strengthen Amplifon's portfolio and market presence [1]. - The CEO of Amplifon, Enrico Vita, is set to provide insights into the acquisition and its implications for the company [2]. Group 2: Communication Logistics - A press release was issued earlier in the day, and the presentation related to the acquisition is available on Amplifon's website in the Investors section [2]. - The call is accessible via webcast and includes dial-in details provided in the press release, ensuring broad accessibility for stakeholders [2].

Amplifon’s Big Bet Has Investors Hearing Alarm Bells - Moby THE GIST Amplifon spent years selling investors a simple story. It was the global hearing care leader with a retail focused model, strong execution and a premium rating to match. Now that story has changed fast. Its €2.3 billion move for GN Hearing is meant to create a bigger and more integrated audiology player, but investors seem to think the company is swapping clarity for complexity at exactly the wrong moment. WHAT HAPPENED Amplifon share ...

Core Viewpoint - GN Store Nord A/S has entered into a definitive agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion, which includes DKK 12.6 billion in cash and 56 million shares in Amplifon, with the transaction expected to close by the end of 2026 [1][14]. Transaction Details - The Hearing business is valued at DKK 17.0 billion on a cash-free and debt-free basis, with the cash component being DKK 12.6 billion and the share component being 56 million shares in Amplifon [1][14]. - The transaction is subject to customary regulatory approvals and the separation of the Hearing business from GN [1][14]. - Following the transaction, GN will hold approximately 16% of Amplifon's current outstanding share capital [14]. Strategic Implications - The merger aims to create a global leader in audiology, combining GN's hearing technology with Amplifon's retail capabilities, benefiting audiologists, consumers, and investors [2][7]. - GN will refocus on the audio and video peripherals markets, leveraging its technology leadership and premium product differentiation [3][6]. - The transaction allows GN to significantly reduce its debt, invest in ongoing business growth, and return capital to shareholders [4][5]. Financial Impact - The Hearing business will be classified as discontinued operations, impacting GN's financial guidance for 2026, which now excludes these operations [10][11]. - GN's organic revenue guidance for 2026 is expected to be between 2% and 8%, with specific growth rates for its Enterprise and Gaming divisions [11][13]. - One-off costs related to the transaction will affect group EBITA in 2026, but a standalone operating system structure is expected to be established thereafter [12]. Future Outlook - GN plans to hold a Capital Markets Day post-transaction to discuss future strategy, long-term financial targets, and capital allocation policies [16]. - The company remains committed to delivering high-quality products and services to customers of the Hearing business until the transaction closes [14].